Testing for the presence of a specific mutation (e.g., Glu6Val for sickle cell anemia or a trinucleotide repeat expansion associated with spinocerebellar ataxia) or set of mutations (e.g., a panel of mutations for cystic fibrosis), as opposed to complete gene sequencing or mutation scanning, which detect most, if not all, mutations in the tested region.